Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HIgh Power Short Duration Radiofrequency Ablation or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation - the HIPAF Trial

NCT04855890 is registered in ClinicalTrials.gov with Universitätsklinikum Köln as lead sponsor.

NCT NCT04855890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04855890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HIgh Power Short Duration Radiofrequency Ablation or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation - the HIPAF Trial
Lead sponsor
Universitätsklinikum Köln
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2021
Completion date
August 1, 2023
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial fibrillation and flutter, paroxysmal atrial fibrillation